Viyash Scientific sets up Vietnam animal health unit under Alivira

Viyash Scientific (NSE: VIYASH) has seen its indirect unit Alivira Vietnam Company Limited incorporated in Vietnam, as a wholly owned step-down subsidiary, it said in a filing on 02 Nov 2026. The entity is expected to import, register, market and distribute animal health products, active pharmaceutical ingredients and phytogenic solutions in Vietnam.

The entity and its stated business

Alivira Vietnam Company Limited was incorporated in Vietnam on 30 Oct 2026. It is a wholly owned subsidiary of Alivira Animal Health Limited, India, which is itself a wholly owned subsidiary of Viyash Scientific, so it sits one level below the listed company.

The entity is expected to undertake the importation, registration, marketing, sale and distribution of animal health products, active pharmaceutical ingredients and phytogenic solutions in Vietnam. It is proposed to sell mainly through a distributor network, while also serving select strategic key accounts directly, and to give commercial, technical and marketing support to customers and business partners.

The company received confirmation of the incorporation on 2 Nov 2026. The filing lists no governmental or regulatory approval as applicable, since the entity has already been incorporated. The entity has become a related party under applicable regulations.

Capital put in and how it fits the group

Alivira Animal Health Limited is investing up to USD 400,000 in cash and holds 100% of the entity's shareholding.

What the Vietnam subsidiary means for Viyash Scientific's shareholders

The step is a small one in the filing: the cash put in is up to USD 400,000, held through Alivira Animal Health Limited. The company does not say how the entity will be funded beyond that amount, when it will start operations, what revenue or profit it may add, how many shares were allotted, or which Vietnamese distributors or key accounts it will use.

At a glance